SELECTION

selection-logo

selectION has established an efficient technology platform to develop highly selective peptide blockers for ion channels. Their most advanced drug candidate is si-544 which is a best-in-class Kv1.3 blocker for treatment of effector memory T cell (TEM) driven diseases. The company is well positioned to expand its range of class-leading ion channel blockers by targeting additional potassium, sodium, calcium and chloride channels, which will lead to other clinical applications in pain management and oncology.

#SimilarOrganizations #People #Financial #Website #More

SELECTION

Industry:
Biotechnology Therapeutics

Founded:
2017-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.selectiontherapeutics.com

Total Employee:
11+

Status:
Active

Total Funding:
9.16 M USD


Similar Organizations

cerevance-logo

Cerevance

Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

feldan-therapeutics-logo

Feldan Therapeutics

Feldan Therapeutics has developed a patented peptide-based technology platform.

scholar-rock-logo

Scholar Rock

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

slingshot-biosciences-logo

Slingshot Biosciences

Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.

Current Employees Featured

antonius-schuh_image

Antonius Schuh
Antonius Schuh CEO @ selectION
CEO
2017-03-01

andreas-klostermann_image

Andreas Klostermann
Andreas Klostermann CSO & Founder @ selectION
CSO & Founder

stephen-zaniboni_image

Stephen Zaniboni
Stephen Zaniboni CFO @ selectION
CFO

Founder


andreas-klostermann_image

Andreas Klostermann

Investors List

global-source-ventures_image

Global Source Ventures

Global Source Ventures investment in Series A - selectION

sdl-ventures_image

SDL Ventures

SDL Ventures investment in Series A - selectION

Official Site Inspections

http://www.selectiontherapeutics.com Semrush global rank: 5.75 M Semrush visits lastest month: 1.45 K

  • Host name: 43.0.153.160.host.secureserver.net
  • IP address: 160.153.0.43
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "selectION" on Search Engine